TWA
TCI Wealth Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-100
| Closed | -$150 | – | 1302 |
|
|
2023
Q1 | $150 | Hold |
100
| – | – | ﹤0.01% | 2365 |
|
|
2022
Q4 | $117 | Hold |
100
| – | – | ﹤0.01% | 2393 |
|
|
2022
Q3 | $0 | Sell |
100
-100
| -50% | – | ﹤0.01% | 2442 |
|
|
2022
Q2 | $0 | Hold |
200
| – | – | ﹤0.01% | 2410 |
|
|
2022
Q1 | $0 | Sell |
200
-1,937
| -91% | – | ﹤0.01% | 2345 |
|
|
2021
Q4 | $5K | Buy |
+2,137
| New | +$5K | ﹤0.01% | 1676 |
|
|
2019
Q1 | – | Sell |
-1,300
| Closed | -$1K | – | 1471 |
|
|
2018
Q4 | $1K | Hold |
1,300
| – | – | ﹤0.01% | 1239 |
|
|
2018
Q3 | $3K | Hold |
1,300
| – | – | ﹤0.01% | 920 |
|
|
2018
Q2 | $3K | Hold |
1,300
| – | – | ﹤0.01% | 951 |
|
|
2018
Q1 | $3K | Hold |
1,300
| – | – | ﹤0.01% | 857 |
|
|
2017
Q4 | $3K | Hold |
1,300
| – | – | ﹤0.01% | 915 |
|
|
2017
Q3 | $4K | Hold |
1,300
| – | – | ﹤0.01% | 782 |
|
|
2017
Q2 | $4K | Hold |
1,300
| – | – | ﹤0.01% | 812 |
|
|
2017
Q1 | $4K | Hold |
1,300
| – | – | ﹤0.01% | 769 |
|
|
2016
Q4 | $5K | Buy |
+1,300
| New | +$5K | ﹤0.01% | 776 |
|